METHOD OF TESTING SENSITIVITY OF SOLID CANCER AGAINST TYROSINE KINASE INHIBITOR AND TEST KIT THEREFOR

摘要

It is intended to provide a method of testing the sensitivity of a solid cancer against a tyrosine kinase inhibitor typified by Gefitinib by using a sample which can be more easily collected, for example, blood or a normal tissue; and a test kit therefor. The expression value of HLA-DQA1 gene or HLA-DQa1 antigen in a sample of a caner patient is measured and then the sensitivity is tested based on the expression value.